SE9903930D0 - Novel compounds and a novel process for their preparation - Google Patents

Novel compounds and a novel process for their preparation

Info

Publication number
SE9903930D0
SE9903930D0 SE9903930A SE9903930A SE9903930D0 SE 9903930 D0 SE9903930 D0 SE 9903930D0 SE 9903930 A SE9903930 A SE 9903930A SE 9903930 A SE9903930 A SE 9903930A SE 9903930 D0 SE9903930 D0 SE 9903930D0
Authority
SE
Sweden
Prior art keywords
novel
preparation
compounds
novel compounds
oxabenzonorbornadienes
Prior art date
Application number
SE9903930A
Other languages
English (en)
Swedish (sv)
Inventor
Keith Fagnou
Mark Lautens
Original Assignee
Astra Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Inc filed Critical Astra Pharma Inc
Priority to SE9903930A priority Critical patent/SE9903930D0/xx
Publication of SE9903930D0 publication Critical patent/SE9903930D0/xx
Priority to ES00975109T priority patent/ES2225253T3/es
Priority to US09/763,759 priority patent/US6525068B1/en
Priority to CNB008177481A priority patent/CN1231439C/zh
Priority to BR0015117-3A priority patent/BR0015117A/pt
Priority to KR1020027005436A priority patent/KR100741177B1/ko
Priority to CA002387675A priority patent/CA2387675C/en
Priority to EP00975109A priority patent/EP1228024B1/en
Priority to JP2001533091A priority patent/JP2003512446A/ja
Priority to SI200030491T priority patent/SI1228024T1/xx
Priority to NZ518451A priority patent/NZ518451A/en
Priority to EP04015462A priority patent/EP1498406A1/en
Priority to DE60013471T priority patent/DE60013471T2/de
Priority to IL14936800A priority patent/IL149368A0/xx
Priority to AU13206/01A priority patent/AU776118B2/en
Priority to AT00975109T priority patent/ATE275120T1/de
Priority to PCT/SE2000/002090 priority patent/WO2001030734A1/en
Priority to MXPA02004224A priority patent/MXPA02004224A/es
Priority to PT00975109T priority patent/PT1228024E/pt
Priority to ZA200203050A priority patent/ZA200203050B/en
Priority to IL149368A priority patent/IL149368A/en
Priority to NO20021968A priority patent/NO328015B1/no
Priority to HK02108588.9A priority patent/HK1047083B/zh
Priority to US10/317,183 priority patent/US6784210B2/en
Priority to US10/855,783 priority patent/US7420003B2/en
Priority to US12/219,752 priority patent/US20080300271A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/38—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. nitrodiphenyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/235—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/253—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/24—Preparation of carboxylic acid esters by reacting carboxylic acids or derivatives thereof with a carbon-to-oxygen ether bond, e.g. acetal, tetrahydrofuran
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
SE9903930A 1999-10-29 1999-10-29 Novel compounds and a novel process for their preparation SE9903930D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE9903930A SE9903930D0 (sv) 1999-10-29 1999-10-29 Novel compounds and a novel process for their preparation
PT00975109T PT1228024E (pt) 1999-10-29 2000-10-26 Novos compostos de hidronaftaleno, preprados por uma reaccao de abertura de anelcatalisada pelo rodio na presenca de um ligando de fosfina
DE60013471T DE60013471T2 (de) 1999-10-29 2000-10-26 Neue hydronaphthalene, hergestellt durch eine rhodium-katalysierte ringöffnungsreaktion in anwesenheit eines phosphinliganden
AU13206/01A AU776118B2 (en) 1999-10-29 2000-10-26 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
CNB008177481A CN1231439C (zh) 1999-10-29 2000-10-26 在膦配体存在下经铑催化的开环反应制备的新的氢化萘化合物
BR0015117-3A BR0015117A (pt) 1999-10-29 2000-10-26 Composto, composição farmacêutica, métodos para tratar um paciente quanto a dor, quanto a doença de parkinson, quanto ao câncer, quanto a aids, processos para preparar um composto, para preparar (1s, 2s) -n- (1-hidróxi-1,2-diidro-naftalen-2-il)- benzeno sulfonamida, e para preparar o éster dimetìlico do áciso (1s*,2r*) -2- (hidróxi -1,2- diidro - naftalen -2- il ) malÈnico
KR1020027005436A KR100741177B1 (ko) 1999-10-29 2000-10-26 포스핀 리간드의 존재하에서 로듐 촉매 고리 열림 반응에의해 제조하는, 신규 히드로나프탈렌 화합물
CA002387675A CA2387675C (en) 1999-10-29 2000-10-26 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
EP00975109A EP1228024B1 (en) 1999-10-29 2000-10-26 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
JP2001533091A JP2003512446A (ja) 1999-10-29 2000-10-26 ホスフィン配位子の存在下のロジウム触媒作用開環反応により製造された新規なヒドロナフタレン化合物
SI200030491T SI1228024T1 (en) 1999-10-29 2000-10-26 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
NZ518451A NZ518451A (en) 1999-10-29 2000-10-26 A hydronaphtalene ring compound, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
EP04015462A EP1498406A1 (en) 1999-10-29 2000-10-26 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand
ES00975109T ES2225253T3 (es) 1999-10-29 2000-10-26 Nuevos compuestos hidronaftalenicos preparados mediante una reaccion de apertura del anillo catalizada por rodio en presencia de un ligando de fosfina.
IL14936800A IL149368A0 (en) 1999-10-29 2000-10-26 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
US09/763,759 US6525068B1 (en) 1999-10-29 2000-10-26 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
AT00975109T ATE275120T1 (de) 1999-10-29 2000-10-26 Neue hydronaphthalene, hergestellt durch eine rhodium-katalysierte ringöffnungsreaktion in anwesenheit eines phosphinliganden
PCT/SE2000/002090 WO2001030734A1 (en) 1999-10-29 2000-10-26 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
MXPA02004224A MXPA02004224A (es) 1999-10-29 2000-10-26 Nuevos compuestos de hidronaftaleno preparados mediante una reaccion de apertura de anillo catalizada por rodio, en presencia de ligando de fosfina.
ZA200203050A ZA200203050B (en) 1999-10-29 2002-04-17 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand.
IL149368A IL149368A (en) 1999-10-29 2002-04-25 Hydronaphthalene compounds, pharmaceutical compositions comprising them, use thereof, and their preparation by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
NO20021968A NO328015B1 (no) 1999-10-29 2002-04-25 Nye hydronaftalenforbindelsen fremstilt ved rhodiumkatalysert ringapningsreaksjon i naervaer av fosfinligand, samt preparater som innbefatter slike forbindelser
HK02108588.9A HK1047083B (zh) 1999-10-29 2002-11-28 在膦配體存在下經銠催化的開環反應製備的新的氫化萘化合物
US10/317,183 US6784210B2 (en) 1999-10-29 2002-12-12 Compound and a novel process for their preparation
US10/855,783 US7420003B2 (en) 1999-10-29 2004-05-28 Compounds and a novel process for their preparation
US12/219,752 US20080300271A1 (en) 1999-10-29 2008-07-28 Novel compounds and a novel process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903930A SE9903930D0 (sv) 1999-10-29 1999-10-29 Novel compounds and a novel process for their preparation

Publications (1)

Publication Number Publication Date
SE9903930D0 true SE9903930D0 (sv) 1999-10-29

Family

ID=20417551

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903930A SE9903930D0 (sv) 1999-10-29 1999-10-29 Novel compounds and a novel process for their preparation

Country Status (20)

Country Link
US (4) US6525068B1 (zh)
EP (2) EP1228024B1 (zh)
JP (1) JP2003512446A (zh)
KR (1) KR100741177B1 (zh)
CN (1) CN1231439C (zh)
AT (1) ATE275120T1 (zh)
AU (1) AU776118B2 (zh)
BR (1) BR0015117A (zh)
CA (1) CA2387675C (zh)
DE (1) DE60013471T2 (zh)
ES (1) ES2225253T3 (zh)
HK (1) HK1047083B (zh)
IL (2) IL149368A0 (zh)
MX (1) MXPA02004224A (zh)
NO (1) NO328015B1 (zh)
NZ (1) NZ518451A (zh)
PT (1) PT1228024E (zh)
SE (1) SE9903930D0 (zh)
WO (1) WO2001030734A1 (zh)
ZA (1) ZA200203050B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1606288T3 (da) * 2003-03-25 2009-10-05 Fournier Lab Sa Benzensulfonamidderivater, fremgangsmåde til fremstilling deraf og deres anvendelse til behandling af smerte
FR2852958B1 (fr) * 2003-03-25 2005-06-24 Fournier Lab Sa Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique
DE502004002403D1 (de) 2003-10-08 2007-02-01 Schering Ag Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102005017316A1 (de) * 2005-04-14 2006-10-19 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP1834948A1 (de) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP2070903A1 (en) 2007-12-12 2009-06-17 Laboratorios del Dr. Esteve S.A. Microwave-assisted ring opening reaction
EP2070904A1 (en) 2007-12-12 2009-06-17 Laboratorios Del. Dr. Esteve, S.A. Rhodium-phosphorus complexes and their use in ring opening reactions
KR101229822B1 (ko) 2008-03-04 2013-02-05 연세대학교 산학협력단 혈관신생 억제용 약제학적 조성물
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP5656364B2 (ja) * 2009-04-20 2015-01-21 株式会社トクヤマ ナフトピラン誘導体の製造方法
SG182522A1 (en) * 2010-01-27 2012-08-30 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent
JP6236785B2 (ja) * 2012-02-28 2017-11-29 株式会社リコー アリールアミン化合物、有機ｅｌ用材料およびその製造方法
CN105399752B (zh) * 2015-11-04 2019-03-15 云南民族大学 一种新型化合物及其制备方法和应用
US11560384B2 (en) 2017-05-04 2023-01-24 University Of Utah Research Foundation Benzonorbornadiene derivatives and reactions thereof
CN108863855B (zh) * 2018-05-29 2020-12-15 云南民族大学 一种合成(1r,2s)-1,2-二氢化萘-1,2-二胺衍生物的方法
CN111471005B (zh) * 2020-05-21 2023-04-07 南方科技大学 一种吲哚-二氢化萘类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301870A1 (en) * 1997-08-27 1999-03-04 Kyowa Hakko Kogyo Co., Ltd. Process for preparing optically active 1,2-diols

Also Published As

Publication number Publication date
CN1413181A (zh) 2003-04-23
KR20020044583A (ko) 2002-06-15
NO328015B1 (no) 2009-11-09
CA2387675C (en) 2010-01-12
ZA200203050B (en) 2003-07-17
CN1231439C (zh) 2005-12-14
DE60013471T2 (de) 2005-09-22
US20080300271A1 (en) 2008-12-04
DE60013471D1 (de) 2004-10-07
US7420003B2 (en) 2008-09-02
HK1047083A1 (en) 2003-02-07
US6525068B1 (en) 2003-02-25
IL149368A (en) 2009-09-01
US6784210B2 (en) 2004-08-31
KR100741177B1 (ko) 2007-07-19
EP1498406A1 (en) 2005-01-19
WO2001030734A1 (en) 2001-05-03
MXPA02004224A (es) 2002-10-17
CA2387675A1 (en) 2001-05-03
EP1228024B1 (en) 2004-09-01
ATE275120T1 (de) 2004-09-15
US20050014721A1 (en) 2005-01-20
IL149368A0 (en) 2002-11-10
NO20021968L (no) 2002-06-05
JP2003512446A (ja) 2003-04-02
US20030144275A1 (en) 2003-07-31
PT1228024E (pt) 2004-12-31
AU776118B2 (en) 2004-08-26
EP1228024A1 (en) 2002-08-07
ES2225253T3 (es) 2005-03-16
NZ518451A (en) 2004-01-30
HK1047083B (zh) 2005-04-29
AU1320601A (en) 2001-05-08
NO20021968D0 (no) 2002-04-25
BR0015117A (pt) 2002-07-16

Similar Documents

Publication Publication Date Title
SE9903930D0 (sv) Novel compounds and a novel process for their preparation
FI20115753A (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
ATE71375T1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
HUP0100815A2 (hu) Neurológiai és neuropszichiátriai rendellenességek kezelésére szolgáló gyógyszerkészítmények
RU99105564A (ru) Способ получения соединений ряда эстеинасцидина
PT84898A (en) Process for the preparation of pharmaceutical compositions comprising 2-phenyl-1,2-benzisoselenazol-3 (2h)-one useful for the treatment of diseases caused by oxidative stress
FI103408B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
DE3773026D1 (de) Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung, sowie diese verbindungen enthaltende arzneimittel.
DE3873578T2 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ES2094742T3 (es) Aminocarbonilcarbamatos relacionados con fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
ATE237610T1 (de) Substituierte dimere carboxamid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
HUP0003174A2 (hu) 20(S)-Kamptotecin glikokonjugátumai, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
WO2001007418A3 (en) Ceramide analogs, process for their preparation and their use as antitumor agents
ES528816A0 (es) Procedimiento de producir compuestos para el tratamiento de la hipertension
EA199700287A1 (ru) Бензамиды для лечения нейродегенеративных заболеваний
PT1123937E (pt) Substancia gm-95 processo para a sua preparacao e a sua utilizacao
FR2359154A1 (fr) Derives peptidiques utiles comme medicaments et procede pour leur preparation
DE69808922D1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
ATE214375T1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
DE69229017D1 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
DZ1704A1 (fr) Dérivés de la n-(phényléthyl-b-ol) amine ainsi queleur procédé de préparation.
MX9704621A (es) Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion.
DE69317803T2 (de) Phorphyrinderivate für Diagnose und photodynamischer Therapie
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.